Angionetics Nears Key Gene Therapy Trial for Coronary Heart Disease – Xconomy
Xconomy |
Angionetics Nears Key Gene Therapy Trial for Coronary Heart Disease
Xconomy Christopher Reinhard will tell you there is nothing unusual about the 20-plus years he's spent getting an experimental heart therapy to late-stage clinical trials. “Very rarely will you get a short story on development of a drug,” said Reinhard (above … |
